PDF(Pubmed)
Abstract：
UNASSIGNED: Millions of acute conjunctivitis cases occur in the United States annually. The impact of COVID-19 mitigation practices on viral conjunctivitis incidence within ophthalmology clinics has not been reported. We hypothesized that viral conjunctivitis rates would decrease with implementation of such practices.
UNASSIGNED: A retrospective chart review was conducted at a single academic center\'s ophthalmology clinics. Electronic health record data was queried using ICD-10 diagnostic codes to include 649 patients aged 2-97 with viral, bacterial, or allergic conjunctivitis diagnosed either before (6/1/2018-5/1/2019) or during (6/1/2020-5/1/2021) COVID-19 precautions. Conjunctivitis rates per ophthalmology clinic visit were compared using rate-ratio analysis. Logistic regression evaluated the effects of age, sex, and race among those with conjunctivitis.
UNASSIGNED: A total of 66,027 ophthalmology clinic visits occurred during the study period. Viral conjunctivitis rates per visit did not significantly change after enacting COVID-19 mitigation strategies, but allergic conjunctivitis rates significantly increased (viral: RR 0.82, 95% CI 0.51 to 1.31, p=0.408; allergic: RR 1.70, 95% CI 1.43 to 2.03, p<0.001). When controlling for time, younger age (≤ median age 55) (p=0.005) and Caucasian race (p=0.009) were associated with higher viral conjunctivitis frequency.
UNASSIGNED: Contrary to trends reported in emergency departments, viral conjunctivitis rates within an ophthalmology clinic did not significantly change after COVID-19 mitigation strategies, though allergic conjunctivitis rates increased. Patients\' avoidance of emergency departments during the pandemic may have contributed. Further investigation is required to explore variation in ophthalmology patient populations and needs based on care setting.
A retrospective review included 649 patients with viral, bacterial, or allergic conjunctivitis diagnosed at a single center’s ophthalmology clinics before (6/1/2018–5/1/2019) or during (6/1/2020–5/1/2021) COVID-19 precautions. Contrary to emergency department experiences, viral conjunctivitis rates did not significantly change after COVID-19 precautions. However, allergic conjunctivitis rates significantly increased. Conjunctivitis presentation in ophthalmology clinics differed from that reported in emergency departments, warranting further evaluation of variation in patient needs by setting.
UNASSIGNED: A retrospective chart review was conducted at a single academic center\'s ophthalmology clinics. Electronic health record data was queried using ICD-10 diagnostic codes to include 649 patients aged 2-97 with viral, bacterial, or allergic conjunctivitis diagnosed either before (6/1/2018-5/1/2019) or during (6/1/2020-5/1/2021) COVID-19 precautions. Conjunctivitis rates per ophthalmology clinic visit were compared using rate-ratio analysis. Logistic regression evaluated the effects of age, sex, and race among those with conjunctivitis.
UNASSIGNED: A total of 66,027 ophthalmology clinic visits occurred during the study period. Viral conjunctivitis rates per visit did not significantly change after enacting COVID-19 mitigation strategies, but allergic conjunctivitis rates significantly increased (viral: RR 0.82, 95% CI 0.51 to 1.31, p=0.408; allergic: RR 1.70, 95% CI 1.43 to 2.03, p<0.001). When controlling for time, younger age (≤ median age 55) (p=0.005) and Caucasian race (p=0.009) were associated with higher viral conjunctivitis frequency.
UNASSIGNED: Contrary to trends reported in emergency departments, viral conjunctivitis rates within an ophthalmology clinic did not significantly change after COVID-19 mitigation strategies, though allergic conjunctivitis rates increased. Patients\' avoidance of emergency departments during the pandemic may have contributed. Further investigation is required to explore variation in ophthalmology patient populations and needs based on care setting.
A retrospective review included 649 patients with viral, bacterial, or allergic conjunctivitis diagnosed at a single center’s ophthalmology clinics before (6/1/2018–5/1/2019) or during (6/1/2020–5/1/2021) COVID-19 precautions. Contrary to emergency department experiences, viral conjunctivitis rates did not significantly change after COVID-19 precautions. However, allergic conjunctivitis rates significantly increased. Conjunctivitis presentation in ophthalmology clinics differed from that reported in emergency departments, warranting further evaluation of variation in patient needs by setting.
摘要：
■美国每年发生数百万例急性结膜炎。COVID-19缓解措施对眼科诊所病毒性结膜炎发病率的影响尚未报道。我们假设病毒性结膜炎的发病率会随着这种做法的实施而降低。
■在一个学术中心的眼科诊所进行了回顾性图表审查。使用ICD-10诊断代码查询电子健康记录数据，包括649名2-97岁的病毒感染者，细菌,或在COVID-19预防措施之前（2018年6月1日至2019年5月1日）或期间（2020年6月1日至2021年5月1日）诊断的过敏性结膜炎。使用比率分析比较了每次眼科门诊就诊的结膜炎率。Logistic回归评估了年龄的影响，性别,以及结膜炎患者的种族。
■在研究期间共进行了66,027次眼科门诊就诊。在制定COVID-19缓解策略后，每次就诊的病毒性结膜炎率没有显著变化，但过敏性结膜炎的发病率显著增加(病毒:RR0.82,95%CI0.51~1.31,p=0.408;过敏:RR1.70,95%CI1.43~2.03,p<0.001)。当控制时间时，年龄较小(≤中位年龄55岁)(p=0.005)和高加索种族(p=0.009)与较高的病毒性结膜炎发生率相关.
■与急诊部门报告的趋势相反，在COVID-19缓解策略后，眼科诊所的病毒性结膜炎率没有显著变化，虽然过敏性结膜炎的发病率增加。在大流行期间，患者避免急诊室可能是有原因的。需要进一步调查以探索基于护理环境的眼科患者人群和需求的变化。
一项回顾性研究包括649例病毒性疾病患者，细菌,或在COVID-19预防措施之前（2018年6月1日至2019年5月1日）或期间（2020年6月1日至2021年5月1日）在单中心眼科诊所诊断出的过敏性结膜炎.与急诊科的经验相反，采取COVID-19预防措施后，病毒性结膜炎的发生率没有显着变化。然而,过敏性结膜炎的发病率显著增加。眼科诊所的结膜炎表现与急诊科的报告不同，保证通过设置进一步评估患者需求的变化。
■在一个学术中心的眼科诊所进行了回顾性图表审查。使用ICD-10诊断代码查询电子健康记录数据，包括649名2-97岁的病毒感染者，细菌,或在COVID-19预防措施之前（2018年6月1日至2019年5月1日）或期间（2020年6月1日至2021年5月1日）诊断的过敏性结膜炎。使用比率分析比较了每次眼科门诊就诊的结膜炎率。Logistic回归评估了年龄的影响，性别,以及结膜炎患者的种族。
■在研究期间共进行了66,027次眼科门诊就诊。在制定COVID-19缓解策略后，每次就诊的病毒性结膜炎率没有显著变化，但过敏性结膜炎的发病率显著增加(病毒:RR0.82,95%CI0.51~1.31,p=0.408;过敏:RR1.70,95%CI1.43~2.03,p<0.001)。当控制时间时，年龄较小(≤中位年龄55岁)(p=0.005)和高加索种族(p=0.009)与较高的病毒性结膜炎发生率相关.
■与急诊部门报告的趋势相反，在COVID-19缓解策略后，眼科诊所的病毒性结膜炎率没有显著变化，虽然过敏性结膜炎的发病率增加。在大流行期间，患者避免急诊室可能是有原因的。需要进一步调查以探索基于护理环境的眼科患者人群和需求的变化。
一项回顾性研究包括649例病毒性疾病患者，细菌,或在COVID-19预防措施之前（2018年6月1日至2019年5月1日）或期间（2020年6月1日至2021年5月1日）在单中心眼科诊所诊断出的过敏性结膜炎.与急诊科的经验相反，采取COVID-19预防措施后，病毒性结膜炎的发生率没有显着变化。然而,过敏性结膜炎的发病率显著增加。眼科诊所的结膜炎表现与急诊科的报告不同，保证通过设置进一步评估患者需求的变化。
